Experienced in Opioid Induced Constipation

Dr. Harshavardhan R. Krishna

Internal Medicine
Health First Medical Center Plc
12100 Dix Toledo Rd, 
Southgate, MI 
Accepting New Patients
Experienced in Opioid Induced Constipation
Health First Medical Center Plc
12100 Dix Toledo Rd, 
Southgate, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Harshavardhan Krishna is a primary care provider, practicing in Internal Medicine in Southgate, Michigan. Dr. Krishna is rated as an Experienced provider by MediFind in the treatment of Opioid Induced Constipation. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Sitosterolemia, and Opioid Induced Constipation. Dr. Krishna is currently accepting new patients.

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in MI
Hospital Affiliations
Wyandotte Hospital And Medical Center
Languages Spoken
English
Hindi
Telugu
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

HEALTH FIRST MEDICAL CENTER PLC
12100 Dix Toledo Rd, Southgate, MI 48195

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Rita K. Kathawa
Advanced in Opioid Induced Constipation
Dr. Rita K. Kathawa
Internal Medicine
Advanced in Opioid Induced Constipation
Dr. Rita K. Kathawa
Internal Medicine

Michigan Weight Loss Institute

41400 Dequindre Road, Suite 105, 
Sterling Heights, MI 
 (28.0 miles away)
586-287-7330
Experience:
8+ years
Languages Spoken:
English, Arabic, Aramaic 
See accepted insurances
Accepting New Patients

Rita Kathawa is an Internal Medicine provider in Sterling Heights, Michigan. Dr. Kathawa has been practicing medicine for over 8 years and is rated as an Advanced provider by MediFind in the treatment of Opioid Induced Constipation. Her top areas of expertise are Obesity, Obesity in Children, Opioid Induced Constipation, and Vitamin D Deficiency. Dr. Kathawa is currently accepting new patients.

Advanced in Opioid Induced Constipation
Dr. Hassen A. Saleh
Internal Medicine
Advanced in Opioid Induced Constipation
Dr. Hassen A. Saleh
Internal Medicine
3270 Greenfield Rd, 
Berkley, MI 
 (19.5 miles away)
248-268-1525
Languages Spoken:
English
See accepted insurances

Hassen Saleh is a primary care provider, practicing in Internal Medicine in Berkley, Michigan. Dr. Saleh is rated as a Distinguished provider by MediFind in the treatment of Opioid Induced Constipation. His top areas of expertise are Tracheitis, Sinusitis, Empyema, and Cellulitis.

Advanced in Opioid Induced Constipation
Dr. Ghazwan A. Atto
Internal Medicine
Advanced in Opioid Induced Constipation
Dr. Ghazwan A. Atto
Internal Medicine

Downriver Medical Associates

2300 Biddle Avenue, Suite 100, 
Wyandotte, MI 
 (1.9 miles away)
734-246-5705
Experience:
33+ years
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Ghazwan Atto is a primary care provider, practicing in Internal Medicine in Wyandotte, Michigan. Dr. Atto has been practicing medicine for over 33 years and is rated as a Distinguished provider by MediFind in the treatment of Opioid Induced Constipation. His top areas of expertise are Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, Endoscopy, and Gastrostomy. Dr. Atto is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Krishna's expertise for a condition
ConditionClose
        View All 19 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile